Han.biomedical Inc. (TPEX:6999)
33.30
-0.15 (-0.45%)
At close: Feb 11, 2026
Han.biomedical Company Description
Han.biomedical Inc. develops structured biomaterials for tissue regeneration in Taiwan.
It offers BarriGel adhesion prevention gel; HANBIO patient lubricant; HANCARE collagen matrix; HANBIO gauze; and LEOFOR hyaluronic acid solution.
The company is based in New Taipei City, Taiwan.
Han.biomedical Inc.
| Country | Taiwan |
| Industry | Biological Products, Except Diagnostic Substances |
| CEO | Changhui Chen |
Contact Details
Address: No. 99, Xintai 5th Road New Taipei City, 221 Taiwan | |
| Phone | 886 2 2697 1328 |
| Website | hanbiomedical.com |
Stock Details
| Ticker Symbol | 6999 |
| Exchange | Taipei Exchange |
| Reporting Currency | TWD |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Changhui Chen | Chief Executive Officer |
| Futa Li | Chief Financial Officer |
| Qing-Xiong Liu | Chief Operating Officer |